Patent ID: 7985768

Claim:
A compound according to formula (I), or a pharmaceutically acceptable salt thereof, wherein n is 0, 1, 2, 3, or 4; R1, at each occurrence, is independently selected from the group consisting of alkyl, alkoxylalkyl, haloalkyl, hydroxyalkyl, oxo, R4O2C—, RcRdNC(O)—, and RcRdNS(O)2—; two R1 together with the same carbon atom to which they are attached, optionally form a 4-, 5-, or 6-membered monocyclic cycloalkyl; R2 is selected from the group consisting of aryl, cycloalkyl, heterocycle, and ReRfN—; R3 is selected from the group consisting of alkyl, alkoxyalkyl, haloalkyl, hydroxyalkyl, R5—C(O)—, R5-C(═N—ORp)—, R6OC(O)—, RgRjNC(O)—, R5-S(O)2—, and RgRjNS(O)2-; R4 is selected from the group consisting of alkyl, arylalkyl, haloalkyl, and heterocycloalkyl; R5, at each occurrence, is selected from the group consisting of alkyl, alkoxyalkyl, aryl, cycloalkyl, haloalkyl, heteroaryl, and heterocycle; R6 is selected from the group consisting of alkyl, arylalkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, heterocycloalkyl, and heteroarylalkyl; Rc and Rd, at each occurrence, are each independently selected from the group consisting of hydrogen, alkyl, and haloalkyl, or Rc and Rd together with the nitrogen atom to which they are attached form a heterocyclic ring; Re is selected from the group consisting of hydrogen, alkyl, haloalkyl, cycloalkylalkyl, and alkylcarbonyl; Rf is selected from the group consisting of hydrogen, alkyl, and haloalkyl; Rg, at each occurrence, is independently selected from the group consisting of alkyl, alkenyl, alkynyl, cycloalkyl, hydroxyalkyl, alkoxyalkyl, arylalkyl, cycloalkylalkyl, haloalkyl, heteroarylalkyl, and heterocycloalkyl; Rj, at each occurrence, is independently selected from the group consisting of hydrogen, alkyl, and haloalkyl; and Rp is selected from the group consisting of hydrogen and alkyl.